Involvement of central cholinergic mechanisms in the effects of oxytocin and an oxytocin receptor antagonist on retention performance in mice

Neurobiology of Learning and Memory

Volumn 74, Issue 3, 2000, Pages 217-228

  Boccia, Mariano M ^a   Baratti, Carlos M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Acetylcholine; Oxytocin; Oxytocin antagonists memory; Oxytocin receptors memory

Indexed keywords

ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; HEXAMETHONIUM; MECAMYLAMINE; METHYLATROPINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NEOSTIGMINE; OXYTOCIN; OXYTOCIN ANTAGONIST; OXYTOCIN PENTAMETHYLENE[2 (METHYLTYROSINE) 4 THREONINE 9 THYMINAMIDE]; OXYTOCIN RECEPTOR; PHYSOSTIGMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LEARNING; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; SHOCK; TASK PERFORMANCE; TRAINING;

EID: 0033732630     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1006/nlme.1999.3954     Document Type: Article

References (55)

1. Entry and distribution of hexamethonium in the central nervous system
2. Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: A review and some new results
3. Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic receptor antagonist
4. Memory facilitation with posttrial injection of physostigmine and oxotremorine in mice
5. Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice
6. The post-training memory enhancement induced by physostigmine and oxotremorine in mice is not state-dependent
7. Facilitation of memory storage by the acetylcholine M2 muscarinic receptor antagonist AF-DX 116
8. Vasopressin and oxytocin receptors in the central nervous system
9. Effects of oxytocin and an oxytocin receptor antagonist on retention of a nose-poke habituation response in mice
10. The enhancement of retention performance induced by picrotoxin in mice may be mediated through a release of endogenous vasopressin
11. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice
12. Oxytocin, vasopressin and memory: Opposite effects on consolidation and retrieval processes
13. A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventricles
14. Muscarinic receptor agonists and antagonists
15. Vasopressin: Localization and putative function in the brain
16. Modulation of social memory in male rats by neurohypophyseal peptides
17. Central nervous system effects of the neurohypophyseal hormones and related peptides
18. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: Mediation by a cerebral neurohypophyseal hormone receptor?
19. Central target for the behavioral effects of vasopressin neuropeptides
20. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory
21. 9] OVT: A selective OT receptor ligand
22. Neurohypophyseal hormone receptors: Relation to behavior
23. Behavioral consequences of intracerebral vasopressin and oxytocin: Focus on learning and memory
24. The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms
25. Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10 Years of research
26. Cholinergic receptor interactions and their effects on long-term memory
27. Neurohypophysial peptides depress cholinergic transmission in a mammalian sympathetic ganglion
28. Memory-improving actions of glucose: Involvement of a central cholinergic muscarinic mechanism
29. Peptidergic modulation of learning and memory processes
30. Role of oxytocin in memory and amnesia
31. Neurohypophysial peptides and brain neurochemistry
32. Intracerebrally released vasopressin and oxytocin: Measurement, mechanisms and behavioral consequences
33. Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation
34. Behavioral effects of peripheral administration of arginine vasopressin: A review of our search for a mode of action and a hypothesis
35. Nicotinic systems and cognitive function
36. Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin Journal of Receptor Research
37. Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine
38. Attenuation of experimentally induced amnesia
39. Changes in acetylcholine content of different brain regions of the rat during a learning experiment
40. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage
41. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): Half-times of disappearance of these neuropeptides from CSF
42. Observations on the pharmacology of mecamylamine
43. Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate and aspartate-induced currents in horizontal cells dissociated from the catfish retina
44. The anatomy of a memory modulatory system: From periphery to brain
45. Opposite actions of oxytocin and its peptide antagonists on social memory in rats
46. Hippocampal acetylcholine release during memory testing in rats: Augmentation by glucose
47. Choline uptake and permanent memory storage
48. Vasopressin and oxytocin in the central nervous system
49. A critique of the vasopressin-memory hypothesis
50. Effect of physiological doses of vasopressin and oxytocin on avoidance and exploratory behaviour in rats
51. Acetylcholinesterase agents
52. Differential hippocampal and cortical cholinergic activation during the acquisition, retention, reversal and extinction of a spatial discrimination in a 8-arm maze by mice
53. Can neurohypophyseal hormones cross the blood-cerebrospinal fluid barrier?